Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Business Of Biotech
00:00
How to Rally Support for a Microbiome Venture
The microbiome field is a little bit suffering, as we speak today, it's true. Having been good investors since the get-go was important. We have always involved them into the design of the trial. We really value their inputs. France is also in a little bit specific regarding the macro volume. Among the six most prolific publisher of patents, three are French academic institutions.
Transcript
Play full episode
